31 July 2026 - Karyopharm Therapeutics Inc (Nasdaq:KPTI), a commercial-stage pharmaceutical company developing novel cancer therapies, on Thursday announced topline results from its Phase 3 XPORT-EC-042 trial evaluating XPOVIO (selinexor) as a mainte...
31 July 2026 - Portugal-based Proteotype Diagnostics Unipessoal LDA on Thursday unveiled Alchemi, its proprietary data and clinical workflow platform being developed for Enlighten, the company's investigational blood-based multi-cancer test.Enli...
31 July 2026 - US-based biotechnology company Kaigene Inc announced on Thursday that it has entered into an exclusive licensing agreement with Japanese pharmaceutical company Taisho Pharmaceutical Co Ltd for the exclusive development and commercialis...
31 July 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Thursday that its board of directors has declared a dividend of USD2.52 per share for the third quarter of 2026.This amount is unchanged from the previous quarterly dividend...
30 July 2026 - Stevanato Group S.p.A. (NYSE:STVN), a provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, announced on Thursday that liraglutide-based combination pro...